EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma – results from a German tertiary medical center

Ann-Kristin Struckmeier iD, Mayte Buchbender, Rainer Lutz, Marco Kesting

Clinical Oral Investigations · 20.04.2024 · 28 (5)

DOI: 10.1007/s00784-024-05644-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Investigations, online erschienen am 20.04.2024. Verfasst von Ann-Kristin Struckmeier und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen- Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germa…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Erlangen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to explore survival and recurrence patterns in patients undergoing primarily surgical treatment for oral squamous cell carcinoma (OSCC) at a high-volume tertiary medical center in Germany. Materials and methods The study included 421 patients with primary OSCC who underwent radical tumor resection, neck dissection, and reconstruction with a free flap. Prognostic relevance of clinicopathological characteristics was assessed using Cox proportional-hazards models. Kaplan-Meier method estimated local recurrence-free survival, progression-free survival (PFS), and overall survival (OS), while the log-rank test compared survival outcomes between groups.

Results

Recurrence manifested in 16.63% of the patients (70 patients), encompassing local recurrence in 54 patients (77.14%) and distant metastasis in 24 patients (34.28%). Neck recurrence occurred in only 1 patient (0.24%) on the contralateral side. The majority of recurrences occurred within the initial twelve months following primary tumor surgery (64.29%). Overall, the 5-year OS stood at 58.29%, while the 5-year PFS reached 72.53%. Patients with early recurrence within ≤ 12 months showed the least favorable prognosis (log-rank, all p < 0.001).

Conclusions

Our findings show a significant decrease in recurrence rates and enhanced PFS at a high-volume tertiary medical center in Germany compared to previous studies. Local recurrence was the primary form observed, with most recurrences happening within the initial twelve months post-surgery. Opting for treatment at a high-volume center and devising therapy plans in interdisciplinary tumor boards may not only enhance OS but also contribute to improved PFS. Clinical relevance These findings offer valuable insights for physicians regarding the post-treatment care of patients with OSCC. The results underscore the importance of frequent follow-up appointments, particularly during the initial year, and highlight the critical need for vigilance in monitoring for local recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsHead and Neck NeoplasmsHumansProgression-Free SurvivalSquamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalRetrospective StudiesPrognosis

Stichwörter der Autor:innen

Free flapNeck dissectionOral squamous cell carcinomaRecurrenceSurvival

Autor:innen und Institutionen

  • Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen- Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany. ak.struckmeier@gmx.de.
  • Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER- EMN), Erlangen, Germany. ak.struckmeier@gmx.de.
  • Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen- Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.
  • Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER- EMN), Erlangen, Germany.

ORCID-Profile: Ann-Kristin Struckmeier

Förderung

  • Universitätsklinikum Erlangen

Zitieren

APA

Struckmeier, A. K., Buchbender, M., Lutz, R., & Kesting, M. (2024). Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma – results from a German tertiary medical center. Clinical Oral Investigations, 28(5). https://doi.org/10.1007/s00784-024-05644-z

Vancouver

Struckmeier AK, Buchbender M, Lutz R, Kesting M. Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma – results from a German tertiary medical center. Clinical Oral Investigations. 2024;28(5). doi:10.1007/s00784-024-05644-z

BibTeX
@article{Struckmeier2024,
  author = {Struckmeier, Ann-Kristin and Buchbender, Mayte and Lutz, Rainer and Kesting, Marco},
  title = {Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma – results from a German tertiary medical center},
  journal = {Clinical Oral Investigations},
  year = {2024},
  volume = {28},
  number = {5},
  doi = {10.1007/s00784-024-05644-z}
}
Kostenlos starten →